IMS Health is an American company that provides information, services and technology for the healthcare industry. It is the largest vendor of U.S. physician prescribing data. IMS Health was founded in 1954 by Bill Frohlich and David Dubow. In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners. The company went public on April 4, 2014 and began trading on the NYSE under the symbol IMS. Ari Bousbib is IMS Health’s Chairman and CEO. Bousbib, formerly a longtime senior executive at United Technologies Corporation, joined the company in September 2010. IMS Health is headquartered in Danbury, Connecticut.

Property Value
dbo:abstract
  • Présente dans 135 pays, IMS Health est une entreprise américaine proposant des études et du conseil pour les industries du médicament et les acteurs de la santé. Selon le classement Vault 2012, IMS Health est la seconde meilleure entreprise de conseil dans le secteur pharmaceutique, entre McKinsey et le Boston Consulting Group. Pour les laboratoires pharmaceutiques, de santé grand public, de parapharmacie, les principaux domaines d’expertise proposés sont : En juin 2014 IMS Health fait une proposition de rachat de plus de 50 % des activités du groupe Cegedim, soit toute la division « CRM et données stratégiques » et la majorité des services informatiques, pour un montant de 385 M€, la transaction a été finalisée le 1er avril 2015. Le 11 février 2016, IMS Health France annonce le début de négociations avec les syndicats et les IRP pour lancer un PSE comportant plus de 20% de suppressions d'emplois et un regroupement de ses activités franciliennes sur la Défense. (fr)
  • IMS Health ist ein US-amerikanisches Unternehmen mit Firmensitz in Danbury, Connecticut, das in der Marktforschung tätig ist und insbesondere Pharmazie- und Gesundheitsunternehmen (Kostenträger, Ärzte und Krankenhäuser) in diesem Sektor berät. Im Unternehmen sind rund 7.600 Mitarbeiter beschäftigt, davon über 300 Mitarbeiter in der deutschen Zentrale in Frankfurt am Main bzw. in München und Bonn. IMS Health wird seit April 2014 an der New Yorker Börse (New York Stock Exchange / NYSE) unter dem Symbol „IMS“ gehandelt. (de)
  • IMS Health è una multinazionale che supporta l'industria farmaceutica attraverso la fornitura di informazioni, analisi e servizi di consulenza. IMS Health è stata fondata nel 1954 da Bill Froch e David Dow. Attualmente IMS opera in più di 100 Paesi, con oltre 6.900 dipendenti, con entrate per 2 miliardi di dollari USA. Ha recentemente trasferito il suo quartier generale da Fairfield a Norwalk, sempre nel Connecticut. (it)
  • アイ・エム・エス・ジャパン株式会社(IMS Japan K.K.)は、世界100ヶ国以上の医療業界に最先端の医療情報と高度なテクノロジー、サービスを提供するグローバル企業 米IMS Health Inc. の日本法人。 (ja)
  • IMS Health is an American company that provides information, services and technology for the healthcare industry. It is the largest vendor of U.S. physician prescribing data. IMS Health was founded in 1954 by Bill Frohlich and David Dubow. In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners. The company went public on April 4, 2014 and began trading on the NYSE under the symbol IMS. Ari Bousbib is IMS Health’s Chairman and CEO. Bousbib, formerly a longtime senior executive at United Technologies Corporation, joined the company in September 2010. IMS Health is headquartered in Danbury, Connecticut. (en)
dbo:foundingYear
  • 1954-01-01 (xsd:date)
dbo:industry
dbo:location
dbo:numberOfEmployees
  • 14000 (xsd:integer)
dbo:owner
dbo:owningCompany
dbo:revenue
  • 3.3
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 4216688 (xsd:integer)
dbo:wikiPageRevisionID
  • 704251832 (xsd:integer)
dbp:foundation
  • 1954 (xsd:integer)
dbp:homepage
dbp:industry
  • Healthcare, Information Services, Technology (en)
dbp:location
dbp:name
  • Ims Health Inc. (en)
dbp:numEmployees
  • 14000 (xsd:integer)
dbp:owner
dbp:revenue
  • $3.3B (en)
dbp:type
dbp:wordnet_type
dct:subject
rdf:type
rdfs:comment
  • IMS Health ist ein US-amerikanisches Unternehmen mit Firmensitz in Danbury, Connecticut, das in der Marktforschung tätig ist und insbesondere Pharmazie- und Gesundheitsunternehmen (Kostenträger, Ärzte und Krankenhäuser) in diesem Sektor berät. Im Unternehmen sind rund 7.600 Mitarbeiter beschäftigt, davon über 300 Mitarbeiter in der deutschen Zentrale in Frankfurt am Main bzw. in München und Bonn. IMS Health wird seit April 2014 an der New Yorker Börse (New York Stock Exchange / NYSE) unter dem Symbol „IMS“ gehandelt. (de)
  • IMS Health è una multinazionale che supporta l'industria farmaceutica attraverso la fornitura di informazioni, analisi e servizi di consulenza. IMS Health è stata fondata nel 1954 da Bill Froch e David Dow. Attualmente IMS opera in più di 100 Paesi, con oltre 6.900 dipendenti, con entrate per 2 miliardi di dollari USA. Ha recentemente trasferito il suo quartier generale da Fairfield a Norwalk, sempre nel Connecticut. (it)
  • アイ・エム・エス・ジャパン株式会社(IMS Japan K.K.)は、世界100ヶ国以上の医療業界に最先端の医療情報と高度なテクノロジー、サービスを提供するグローバル企業 米IMS Health Inc. の日本法人。 (ja)
  • IMS Health is an American company that provides information, services and technology for the healthcare industry. It is the largest vendor of U.S. physician prescribing data. IMS Health was founded in 1954 by Bill Frohlich and David Dubow. In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners. The company went public on April 4, 2014 and began trading on the NYSE under the symbol IMS. Ari Bousbib is IMS Health’s Chairman and CEO. Bousbib, formerly a longtime senior executive at United Technologies Corporation, joined the company in September 2010. IMS Health is headquartered in Danbury, Connecticut. (en)
  • Présente dans 135 pays, IMS Health est une entreprise américaine proposant des études et du conseil pour les industries du médicament et les acteurs de la santé. Selon le classement Vault 2012, IMS Health est la seconde meilleure entreprise de conseil dans le secteur pharmaceutique, entre McKinsey et le Boston Consulting Group.Pour les laboratoires pharmaceutiques, de santé grand public, de parapharmacie, les principaux domaines d’expertise proposés sont : (fr)
rdfs:label
  • IMS Health (de)
  • IMS Health (en)
  • IMS Health (fr)
  • IMS Health (it)
  • アイエムエスジャパン (ja)
owl:sameAs
prov:wasDerivedFrom
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Ims Health Inc. (en)
is dbo:wikiPageDisambiguates of
is dbo:wikiPageRedirects of
is foaf:primaryTopic of